FDA Arthritis Advisory Committee meeting.
D000893:Anti-Inflammatory Agents / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury; D004348:Drug Labeling / Q000592:standards; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000893:Anti-Inflammatory Agents